Creative Medical Technology Holdings, Inc. Repayments of Related Party Debt
Creative Medical Technology Holdings, Inc. (CELZ) reported Repayments of Related Party Debt of $200.00 thousand for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-08.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfRelatedPartyDebt · last filed 2024-11-08
- Creative Medical Technology Holdings, Inc. repayments of related party debt for the quarter ending 2022-12-31 was $0.00.
- Creative Medical Technology Holdings, Inc. repayments of related party debt for the quarter ending 2021-12-31 was $0.00.
- Creative Medical Technology Holdings, Inc. repayments of related party debt for the quarter ending 2019-12-31 was $0.00.
- Creative Medical Technology Holdings, Inc. repayments of related party debt for the quarter ending 2018-12-31 was $0.00.
- Creative Medical Technology Holdings, Inc. repayments of related party debt for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- Creative Medical Technology Holdings, Inc. repayments of related party debt for fiscal 2021 was $220.00K.
- Creative Medical Technology Holdings, Inc. repayments of related party debt for fiscal 2019 was $50.00K.
- Creative Medical Technology Holdings, Inc. repayments of related party debt for fiscal 2018 was $0.00.
| Period end | Repayments of Related Party Debt 3 month | Repayments of Related Party Debt 6 month | Repayments of Related Party Debt 9 month | Repayments of Related Party Debt 12 month |
|---|---|---|---|---|
| 2024-09-30 | $200.00K 10-Q · filed 2024-11-08 | |||
| 2023-09-30 | $100.00K 10-Q · filed 2024-11-08 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $0.00 10-K · filed 2023-03-31 | ||
| 2022-09-30 | $0.00 10-Q · filed 2022-11-10 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $220.00K 10-K · filed 2023-03-31 | ||
| 2021-09-30 | $220.00K 10-Q · filed 2022-11-10 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-06 | $50.00K 10-K · filed 2020-04-06 | ||
| 2019-09-30 | $50.00K 10-Q · filed 2019-11-14 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-06 | $0.00 10-K · filed 2020-04-06 | ||
| 2018-09-30 | $0.00 10-Q · filed 2019-11-14 | |||
| 2015-12-31 | $0.00 10-K · filed 2016-04-14 | |||
| 2014-12-31 | $0.00 10-K · filed 2016-04-14 | |||
| 2014-03-31 | $0.00 10-Q · filed 2014-05-13 | $5.03K derived: sum of 2 quarters · filed 2015-02-27 | ||
| 2013-12-31 | $5.03K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $13.35K 10-K · filed 2015-02-27 | ||
| 2013-09-30 | $8.32K 10-Q · filed 2013-11-13 | |||
| 2013-03-31 | $0.00 10-Q · filed 2014-05-13 | $0.00 derived: sum of 2 quarters · filed 2014-05-13 | ||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | $0.00 10-K · filed 2014-03-17 | ||
| 2012-09-30 | $0.00 10-Q · filed 2013-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |